Matches in Wikidata for { <http://www.wikidata.org/entity/Q89155518> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q89155518 description "clinical trial" @default.
- Q89155518 description "ensayu clínicu" @default.
- Q89155518 description "klinisch onderzoek" @default.
- Q89155518 description "клінічне випробування" @default.
- Q89155518 name "Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19" @default.
- Q89155518 name "Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19" @default.
- Q89155518 name "Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19" @default.
- Q89155518 type Item @default.
- Q89155518 label "Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19" @default.
- Q89155518 label "Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19" @default.
- Q89155518 label "Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19" @default.
- Q89155518 prefLabel "Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19" @default.
- Q89155518 prefLabel "Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19" @default.
- Q89155518 prefLabel "Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19" @default.
- Q89155518 P1132 Q89155518-69A2BEC6-5A36-4A5B-8F82-4A95344BE91D @default.
- Q89155518 P1476 Q89155518-FD3A64B8-4DDD-43A4-BCBA-1B3FC0FCA7E1 @default.
- Q89155518 P17 Q89155518-8A707A50-A7A9-4490-87E2-88542AA81C9F @default.
- Q89155518 P2899 Q89155518-F266E3DE-6659-44C1-8266-84AAAB39E9E6 @default.
- Q89155518 P3098 Q89155518-C66A8737-A255-49C3-9544-76EEA46168FA @default.
- Q89155518 P31 Q89155518-46CDE68A-035E-4B8A-8A2C-7FD1A057B965 @default.
- Q89155518 P580 Q89155518-82690224-BA6C-4E06-99FA-0B4C0EF1DA2D @default.
- Q89155518 P582 Q89155518-F51CBB98-D967-4E74-AEE9-0C14C2E5AD32 @default.
- Q89155518 P6099 Q89155518-2D8CF68D-2969-426C-ADA7-817CD2D5D37A @default.
- Q89155518 P6099 Q89155518-B6E8D34D-141A-4BEA-A221-6FDD6F074470 @default.
- Q89155518 P767 Q89155518-9C4AD4D5-AE62-4012-92C8-C60D4E0AC54E @default.
- Q89155518 P8363 Q89155518-8BE3B928-AABF-4C49-9081-09E8C169B37E @default.
- Q89155518 P921 Q89155518-BC0D56DD-4E90-444F-A673-5DE6D1B41C54 @default.
- Q89155518 P1132 "+400" @default.
- Q89155518 P1476 "An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients With COVID-19" @default.
- Q89155518 P17 Q30 @default.
- Q89155518 P2899 "+18" @default.
- Q89155518 P3098 "NCT04315298" @default.
- Q89155518 P31 Q30612 @default.
- Q89155518 P580 "2020-03-16T00:00:00Z" @default.
- Q89155518 P582 "2021-03-16T00:00:00Z" @default.
- Q89155518 P6099 Q42824440 @default.
- Q89155518 P6099 Q42824827 @default.
- Q89155518 P767 Q158205 @default.
- Q89155518 P8363 Q78089383 @default.
- Q89155518 P921 Q84263196 @default.